Landscapes / Targets
gp100
2 drugs act on gp100, in 4 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Bispecific gp100 peptide-hla-directed CD3 T cell engager |
Approved | Mar 2028Phase 3 trial completes | |||
| Next date | Mar 2028 · Phase 3 trial completes | ||||
| Also tested for | Select Advanced Solid Tumors, Advanced Melanoma | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Jan 2027Phase 2 trial completes | |||
| Next date | 31 Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Malignant Melanoma, Melanoma (Skin) and 6 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 2 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026